Cathepsin D stimulates the activities of secreted plasminogen activators in the breast cancer acidic environment

Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients

(2013) N. Harbeck et al.   EUROPEAN JOURNAL OF CANCER

Plasminogen activator inhibitor 1 - insulin-like growth factor binding protein 3 cascade regulates stress-induced senescence

(2012) David J. Elzi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Proteolytic networks in cancer

(2011) Steven D. Mason et al.   TRENDS IN CELL BIOLOGY

Breast cancer cell surface annexin II induces cell migration and neoangiogenesis via tPA dependent plasmin generation

(2010) Meena Sharma et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Pro-cathepsin D interacts with the extracellular domain of the   chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth

(2010) M. Beaujouin et al.   JOURNAL OF CELL SCIENCE

Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells

(2008) Y. Suzuki et al.   BLOOD

Unliganded estrogen receptor α inhibits breast cancer cell growth through interaction with a cyclin-dependent kinase inhibitor (p21WAF1)

(2007) Marie Maynadier et al.   FASEB JOURNAL